

** Continuing weakness in Shire's share price putting deal to acquire Baxalta under strain as synergies evaporate, according to traders and analysts *...


(ShareCast News) - UBS upgraded HSBC to 'buy' from 'neutral' saying the risk/reward on the shares has shifted to the upside. It noted that since 11 Au...


(ShareCast News) - HSBC upgraded Shire to 'hold' from 'reduce', noting that the shares have fallen below its unchanged price target of 4,734p. Neverth...




(ShareCast News) - Pharmaceuticals company Shire said late on Thursday that a US court of appeals has upheld the summary judgment ruling of the US Dis...